338:HKEXSinopec Shanghai Petrochemical Co. Ltd. Class H Analysis
Data as of 2026-06-10 - not real-time
₩13,100.00
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Y‑Biologics is trading well under its short‑term moving averages, with price below both the 20‑day and 50‑day SMA, and the 14‑day RSI indicates a deep oversold condition. The MACD histogram is negative and the signal line is bearish, reinforcing a downward technical bias.
Fundamentally, the company reports negative operating and profit margins, a substantial operating loss, and a large negative free cash flow, while carrying a high debt‑to‑equity ratio and a price‑to‑sales multiple that far exceeds the industry average. Although the sector is in an extreme greed phase, the lack of earnings, zero dividend and a weak balance sheet suggest the current valuation is not justified by the underlying financial health.
Fundamentally, the company reports negative operating and profit margins, a substantial operating loss, and a large negative free cash flow, while carrying a high debt‑to‑equity ratio and a price‑to‑sales multiple that far exceeds the industry average. Although the sector is in an extreme greed phase, the lack of earnings, zero dividend and a weak balance sheet suggest the current valuation is not justified by the underlying financial health.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Price below key moving averages
- Bearish MACD and deep oversold RSI
- Negative operating cash flow and high debt
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential upside from clinical pipeline if trials succeed
- Continued financial losses and cash burn
- Volatile price action with stable but modest volume
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Long‑term growth prospects in immuno‑oncology
- Large cash reserves relative to market cap
- Industry tailwinds for biotech innovation
Key Metrics & Analysis
Financial Health
Revenue Growth-30.80%
ROE-221.97%
ROA-18.45%
Debt/Equity69.72
Op. Cash Flow₩-6509573120
Free Cash Flow₩-7027488256
Industry P/E24.9
Technical Analysis
TrendNeutral
RSI17.2
Support₩12,710.00
Resistance₩21,700.00
MA 20₩17,493.00
MA 50₩22,162.00
MA 200₩21,561.35
MACDBearish
VolumeStable
Fear & Greed Index85.95
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.05
Volatility40.83%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.